DOGMATYL Side Effects

6696825-2 | Blood Glucose Increased, Glycosylated Haemoglobin Increased, Hyperglycaemia
on Apr 14, 2010 Female patient from JAPAN , 59 years of age, weighting 128.1 lb, was diagnosed with hyperlipidaemia and was treated with Dogmatyl (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, glycosylated haemoglobin increased, hyperglycaemia. Dogmatyl dosage: . During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), RESLIN (View Reslin Review and Reslin Label ). Patient was hospitalized.

6685007-6 | Blood Glucose Increased, Glycosylated Haemoglobin Increased, Hyperglycaemia
Patient was taking Dogmatyl (View Usage). Patient had the following side effects: blood glucose increased, glycosylated haemoglobin increased, hyperglycaemia on Apr 06, 2010 from JAPAN Additional patient health information: Female patient , 59 years of age, weighting 128.1 lb, was diagnosed with hyperlipidaemia and. Dogmatyl dosage: . During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), RESLIN (View Reslin Review and Reslin Label ). Patient was hospitalized.

5441632-1 | Leukoencephalopathy
Adverse event was reported on Aug 24, 2007 by a Female patient taking Dogmatyl (View Usage) (Dosage: Unk) . Location: JAPAN , 70 years of age, After Dogmatyl was administered, patient had the following side effects: leukoencephalopathy. During the same period patient was treated with ZOLPIDEM (Unk) (View Zolpidem Review and Zolpidem Label ), NEUQUINON (Unk) (View Neuquinon Review and Neuquinon Label ), METHYCOBAL (Unk) (View Methycobal Review and Methycobal Label ), RABEPRAZOLE SODIUM (Unk) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), MEDICON (Unk) (View Medicon Review and Medicon Label ), LANSOPRAZOLE (Unk) (View Lansoprazole Review and Lansoprazole Label ), MUCOSTA (Unk) (View Mucosta Review and Mucosta Label ), PEPCID (Unk) (View Pepcid Review and Pepcid Label ).

5423889-6 | Hepatic Function Abnormal, Liver Function Test Abnormal
on Aug 13, 2007 Male patient from JAPAN , 70 years of age, was treated with Dogmatyl (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic function abnormal, liver function test abnormal. Dogmatyl dosage: Unk. During the same period patient was treated with PLAVIX (Unk) (View Plavix Review and Plavix Label ). Patient was hospitalized.


5355949-2 | Accidental Overdose, Amnesia, Road Traffic Accident
on Jun 01, 2007 Male patient from JAPAN , 16 years of age, weighting 147.7 lb, was treated with Dogmatyl (View Usage). Patient had the following side effects: accidental overdose, amnesia, road traffic accident. Dogmatyl dosage: . During the same period patient was treated with MYSLEE (View Myslee Review and Myslee Label ).

5119422-9 | Anxiety, Drowning, Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hallucination, Muscle Rigidity, Muscle Spasms
Patient was taking Dogmatyl (View Usage). After Dogmatyl was administered, patient had the following side effects: anxiety (What is anxiety?), drowning (What is drowning?), dyskinesia, extrapyramidal disorder, gait disturbance, hallucination, muscle rigidity, muscle spasms on May 26, 2006 from SPAIN Additional patient health information: Female patient , 26 years of age, was diagnosed with motion sickness (What is motion sickness?), vertigo and. Dogmatyl dosage: . During the same period patient was treated with ACETAMINOPHEN (Unk, Unk) (View Acetaminophen Review and Acetaminophen Label ), ALPRAZOLAM (1 Df, Qd) (View Alprazolam Review and Alprazolam Label ), TORECAN (1 Df, Qd) (View Torecan Review and Torecan Label ).

5045501-0 | Anxiety, Drowning, Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hallucination, Muscle Rigidity, Muscle Spasms
Adverse event was reported on May 26, 2006 by a Female patient taking Dogmatyl (View Usage) (Dosage: ) was diagnosed with motion sickness (What is motion sickness?), vertigo and. Location: SPAIN , 26 years of age, Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), drowning (What is drowning?), dyskinesia, extrapyramidal disorder, gait disturbance, hallucination, muscle rigidity, muscle spasms. During the same period patient was treated with PARACETAMOL (Unk, Unk) (View Paracetamol Review and Paracetamol Label ), ALPRAZOLAM (1 Df, Qd) (View Alprazolam Review and Alprazolam Label ), TORECAN (1 Df, Qd) (View Torecan Review and Torecan Label ).

5028605-8 | Anxiety, Drowning, Dyskinesia, Extrapyramidal Disorder, Gait Disturbance, Hallucination, Muscle Rigidity, Muscle Spasms
on May 26, 2006 Female patient from SPAIN , 26 years of age, was diagnosed with motion sickness (What is motion sickness?), vertigo and was treated with Dogmatyl (View Usage). Patient had the following side effects: anxiety (What is anxiety?), drowning (What is drowning?), dyskinesia, extrapyramidal disorder, gait disturbance, hallucination, muscle rigidity, muscle spasms. Dogmatyl dosage: . During the same period patient was treated with PARACETAMOL (Unk, Unk) (View Paracetamol Review and Paracetamol Label ), ALPRAZOLAM (1 Df, Qd) (View Alprazolam Review and Alprazolam Label ), TORECAN (1 Df, Qd) (View Torecan Review and Torecan Label ).

4826896-7 | Depressed Level Of Consciousness, Dysphagia, Pyrexia, Respiratory Disorder, Tremor
on Oct 18, 2005 Female patient from JAPAN , 57 years of age, was diagnosed with ill-defined disorder, depression (What is depression?) and was treated with Dogmatyl (View Usage). After Dogmatyl was administered, patient had the following side effects: depressed level of consciousness, dysphagia, pyrexia, respiratory disorder, tremor. Dogmatyl dosage: Daily Dose: 100 Milligram(s). During the same period patient was treated with FLUVOXAMINE MALEATE (Daily Dose: 100 Milligram(s)) (View Fluvoxamine Maleate Review and Fluvoxamine Maleate Label ), SEPAZON (Daily Dose: 3 Milligram(s)) (View Sepazon Review and Sepazon Label ). Patient was hospitalized.

4798420-9 | Anaphylactoid Reaction, Nausea
Patient was taking Dogmatyl (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactoid reaction, nausea (What is nausea?) on Jul 01, 2005 from JAPAN Additional patient health information: Female patient , weighting 94.80 lb, was diagnosed with cervicobrachial syndrome, intervertebral disc protrusion, epidural anaesthesia and. Dogmatyl dosage: Daily Dose: 150 Milligram(s). During the same period patient was treated with DEPROMEL 25 (Daily Dose: 50 Milligram(s)) (View Depromel 25 Review and Depromel 25 Label ), DEPAS (Daily Dose: 2 Milligram(s)) (View Depas Review and Depas Label ), MOHRUS TAPE (View Mohrus Tape Review and Mohrus Tape Label ), DIBCALSOR (Dosage: 5 Ml, One Time Per Month) (View Dibcalsor Review and Dibcalsor Label ), DEXAMETHASONE ACETATE (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ), MEPIVACAINE HCL (View Mepivacaine Hcl Review and Mepivacaine Hcl Label ).

4725879-5 | Dyspnoea, Nausea, Urticaria
Adverse event was reported on Jul 01, 2005 by a Female patient taking Dogmatyl (View Usage) (Dosage: Daily Dose: 150 Milligram(s)) was diagnosed with cervicobrachial syndrome, intervertebral disc protrusion and. Location: JAPAN , weighting 94.80 lb, Patient had the following side effects: dyspnoea, nausea (What is nausea?), urticaria. During the same period patient was treated with DEPROMEL 25 (Daily Dose: 50 Milligram(s)) (View Depromel 25 Review and Depromel 25 Label ), MEPIVACAINE HCL (Dosage: 20 Ml, One Time Per Month) (View Mepivacaine Hcl Review and Mepivacaine Hcl Label ), DEPAS (Daily Dose: 2 Milligram(s)) (View Depas Review and Depas Label ), MOHRUS TAPE (View Mohrus Tape Review and Mohrus Tape Label ), DEXAMETHASONE ACETATE (Dosage: 1 Dosage Form, One Time Per Month) (View Dexamethasone Acetate Review and Dexamethasone Acetate Label ), DIBCALSOR (Dosage: 5 Ml, One Time Per Month) (View Dibcalsor Review and Dibcalsor Label ).